Twitter

Archive for May 2nd, 2012


The Leading Edge: Small Businesses Bring Novel Cancer Technologies to Market

Eighteen companies funded by NCI’s Small Business Innovation Research (SBIR) Development Center presented the next generation of cancer therapeutics, diagnostics, and devices at the SBIR 2012 Investor Forum, held April 18 at Agilent Technologies in Santa Clara, CA.

Read More...

Survival Differences Persist Between Black and White Children with Cancer

Despite substantial improvements in childhood cancer survival over the past several decades, racial disparities in survival rates persist—and, in fact, have worsened for some cancer types—according to a study published online April 30 in the Journal of Clinical Oncology.

Read More...

Surgical and Radiation Therapies for High-Risk Early Lung Cancer

The name of the trial is Phase III Randomized Study of Sublobar Resection with or without Brachytherapy Versus Stereotactic Body Radiotherapy in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (ACOSOG-Z4099).

Read More...

Hispanics Have Lower Death Rates for Common Lung Cancer

A large population-based analysis of U.S. patients diagnosed with non-small cell lung cancer (NSCLC) indicates that Hispanic white patients have better overall survival than non-Hispanic whites and blacks, according to a report published online April 23 in Cancer.

Read More...

Ovarian Mesial Incision: a New Safe and Fertility-sparing Technique

Condition :   Dermoid Ovarian Cysts Intervention :   Procedure: Laparoscopic dermoid cystectomy Sponsors :   University Magna Graecia;   University Magna Graecia Completed – verified April 2012

Read More...

Reduced Planning Target Volume (PTV) Margins for the Treatment of Prostate Cancer Using the Calypso 4D Localization System

Condition :   Prostate Cancer Intervention :   Sponsors :   U.S. Army Medical Research Acquisition Activity;   Dusten Macdonald, MD;   The Geneva Foundation Recruiting – verified May 2012

Read More...

The Value of Botox-A for Management of Low Anterior Resection Syndrome

Conditions :   Low Anterior Resection Syndrome;   Rectal Cancer Intervention :   Drug: intra-rectal Botulinum toxin A injection Sponsors :   Centre hospitalier de l’Université de Montréal (CHUM);   Centre hospitalier de l’Université de Montréal (CHUM);   Allergan Not yet recruiting – verified June 2011

Read More...

Quality of Life and Sexuality in Women With Gynaecological Cancer

Condition :   Cancer Intervention :   Sponsors :   Rambam Health Care Campus;   Rambam Health Care Campus Not yet recruiting – verified April 2012

Read More...

Doxycycline, Temozolomide and Ipilimumab in Melanoma

Condition :   Melanoma Interventions :   Drug: Doxycycline;   Drug: Ipilimumab;   Drug: Temozolomide Sponsors :   M.D. Anderson Cancer Center;   M.D. Anderson Cancer Center;   National Institutes of Health (NIH);   National Cancer Institute (NCI) Not yet recruiting – verified April 2012

Read More...

Ganetespib With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma

Condition :   Malignant Pleural Mesothelioma (MPM, a Rapidly Lethal Cancer Arising From the Parietal Pleural Mesothelium and is Associated With Exposure to Asbestos. Interventions :   Drug: Ganetespib;   Drug: Placebo Sponsors :   University College, London;   University College, London;   Cancer Research UK Not yet recruiting – verified May 2012

Read More...